Author headshot

Moshe Ornstein, MD

Ornstein is a genitourinary medical oncologist at Cleveland Clinic Taussig Cancer Institute.

Most recent by Moshe Ornstein, MD

SPONSORED CONTENT
March 14, 2023
4 min watch
Save

VIDEO: Triplet therapy shows benefit in intermediate-risk renal cell carcinoma

SAN FRANCISCO — Healio spoke with Moshe Ornstein, MD, about the COSMIC-313 trial presented at the annual ASCO Genitourinary Cancers Symposium.

SPONSORED CONTENT
March 14, 2023
2 min watch
Save

VIDEO: Update from CheckMate 9ER further shows benefit of nivolumab/cabozantinib in RCC

SAN FRANCISCO — In this video, Moshe Ornstein, MD, highlights findings from the follow-up data of the CheckMate 9ER trial presented at the annual ASCO Genitourinary Cancers Symposium.

SPONSORED CONTENT
March 13, 2023
3 min watch
Save

VIDEO: ‘Important’ interim results from CaboPoint trial

SAN FRANCISCO — In this video, Moshe Ornstein, MD, discusses interim results from the CaboPoint study presented at the annual ASCO Genitourinary Cancers Symposium.

SPONSORED CONTENT
March 13, 2023
3 min watch
Save

VIDEO: Small study assesses intermittent ipilimumab, nivolumab metastatic RCC

SAN FRANCISCO — Moshe Ornstein, MD, spoke with Healio about a trial of intermittent therapy in patients with metastatic renal cell carcinoma presented at the annual ASCO Genitourinary Cancers Symposium.